In light of the recent Commission proposal for a revamped European legal framework governing Genetically Modified Organisms (GMOs), corporate legal teams across the globe should brace themselves for significant legislative changes.
The proposal comes following two Confédération Paysanne decisions (cases C-528/16 and C-688/21) in which the Court of Justice of the European Union (CJEU) has sided for the reduction of exclusion of plants and products developed using New Genomic Techniques (NGTs) from the obligations of Directive 2001/18. Under the present laws, only organisms and varieties resulting from conventional mutagenesis techniques were excluded from these requirements, provided they have a long-standing safety record.
As reported by JDSupra, the reinterpretation and redefinition of GMOs would embody new technologies such as gene editing and other forms of genetic manipulation that were not prominent when the current regulations were adopted. This brings GMO regulations into alignment with modern scientific advancements, placing the regulatory landscape in a state of flux.
The Commission proposal could have significant implications for both companies involved in genetic manipulation and those indirectly impacted by these technologies. Amid the shifting legal environment, legal professionals ought to stay alert, anticipate potential challenges, and adapt their strategies to ensure compliance with the ongoing changes in GMO regulations.
Further updates on the Commission proposal and its potential effects on the legal framework surrounding GMOs will be provided as more information becomes available.